United States (US) Corticosteroids Market Top 5 Importing Countries and Market Competition (HHI) Analysis
The United States continues to be a key importer of corticosteroids, with top exporting countries including Italy, Canada, China, India, and Portugal in 2024. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a significant growth rate of 25.16% from 2023 to 2024. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI) in 2024, suggesting strong dominance among the top exporting countries. This data highlights the ongoing importance of corticosteroids imports to meet demand in the US market.
United States Us Corticosteroids Market Synopsis
The United States Corticosteroids market is expected to witness significant growth over the forecast period of 2020-2025. The rising prevalence of various chronic and autoimmune diseases such as asthma, arthritis, lupus erythematosus, inflammatory bowel disease (IBD), and multiple sclerosis are key drivers for the growth of the corticosteroid market in the US. Furthermore, increasing awareness among patients regarding novel delivery forms or modes including inhalers and injectables is anticipated to boost usage rates and further drive revenue generation. Additionally, drug manufacturers have intensified their investment in research & development activities for new product launches across different regions which renders a favorable outlook for this sector over the coming years.
Drivers of the Market
Increasing incidence rate of chronic diseases such as bronchial asthma requiring systemic corticosteroid therapy will contribute significantly towards industry expansion. Higher spending capacity on healthcare treatments has propelled the demand for advanced treatment regimens like corticosteroids delivering improved efficacy outcomes that result in higher patient compliance. Increased availability of effective combination therapies containing steroids along with antibiotics providing enhanced therapeutic benefits compared to monotherapy will fuel sales volume 4. Growing focus on introducing innovative products with combined glucocorticoid/immunomodulator compounds offering additional clinical advantages leading to increased adoption rate by physicians
Challenges of the Market
High risk associated with adverse side effects from long-term use may hamper usage rates thus limiting overall sales revenues generated from this sector. Stringent regulatory framework pertaining to the approval process adding extra cost burden while manufacturing steroid-based drugs can act as a deterrent against industry players.
Key Players of the Market
Pfizer Inc., Merck & Co., Inc., Novartis AG, Sanofi S A, AstraZeneca Plc, AbbVie Inc., GlaxoSmithKline plc, Bristol Myers Squibb Company, etc .are some major innovators contributing significantly towards US Corticosteroids Market Landscape.
Covid-19 Impact on the Market
The outbreak has negatively impacted medical device industries due to disruption in supply chains coupled with a declining global economy resulting in reduced demand due to high costs involved during treatment procedures. However, introducing newer products facilitating efficient usage would play a pivotal role post-pandemic situation thus driving up demand levels and eventually aiding industry development.
Key Highlights of the Report:
- United States (US) Corticosteroids Market Outlook
- Market Size of United States (US) Corticosteroids Market, 2021
- Forecast of United States (US) Corticosteroids Market, 2028
- Historical Data and Forecast of United States (US) Corticosteroids Revenues & Volume for the Period 2018 - 2028
- United States (US) Corticosteroids Market Trend Evolution
- United States (US) Corticosteroids Market Drivers and Challenges
- United States (US) Corticosteroids Price Trends
- United States (US) Corticosteroids Porter's Five Forces
- United States (US) Corticosteroids Industry Life Cycle
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Application for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Skin Allergies for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Rhuematology Indications for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Endocrinology for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Acute Respiratory Diseases for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Others for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By End User for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Hospitals for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Clinics for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Research Institutes for the Period 2018 - 2028
- Historical Data and Forecast of United States (US) Corticosteroids Market Revenues & Volume By Others for the Period 2018 - 2028
- United States (US) Corticosteroids Import Export Trade Statistics
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By End User
- United States (US) Corticosteroids Top Companies Market Share
- United States (US) Corticosteroids Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Corticosteroids Company Profiles
- United States (US) Corticosteroids Key Strategic Recommendations
